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Fatal Dengue Cases in Mukalla - Hadhramout : 
Causes and Alarming Signals 
 
Abdulrahim Abdulla  Bahashwan*     Ahmed Mubarak daakeek* 




A prospective descriptive study was conducted in Ib-Sina Hospital- Mukalla-Hadhramout To identify the causes and 
alarming signal of dengue -related deaths during the 2015-2016 dengue outbreak in Mukalla –Hadhramout- Yemen. 
Deaths due to dengue fever were reviewed from hospital records. Demographic details, clinical features, laboratory 
findings, and the treatment charts of death cases were reviewed and documented. Comorbidities were also listed, and 
causes and warning signs were evaluated and highlighted. Out of 424 dengue fever patients who admitted during 
outbreak period, 18 dengue-related deaths were reported (4.25%); 10 (55.6%) were male, and 8 (44.4%) were female. 
The median age was 26 years. Most cases from Fuwwah and Mukalla city (50%). The diagnosis at the time of 
presentation was severe dengue in all patients. three (15.9%) patients had comorbidity.  Dengue shock, fulminant 
hepatitis, encephalitis and acute respiratory distress syndrome were the most common causes of death. Nausea, 
vomiting, abdominal pain, hypotension, altered mental status, convulsion, leukocytosis, rapid fall in platelet and 
elevated liver enzymes  were alarming signals of fatal dengue. In conclusion Dengue-related deaths often occurs in 
young adult patients and shock state was the most common cause principally in females. Among died patients, raised 
hematocrit were not useful in identifying patients with plasma leakage. The causes and alarm signals for death were 
somewhat similar to other regional studies mostly in Asian countries.  
 
Keywords:   Dengue fever, severe dengue fever, Mukalla, Yemen. 
 
Introduction: 
Dengue is a systemic viral infection transmitted 
between humans by Aedes mosquitoes. For some 
patients, dengue is a life-threatening illness. A 
recent study estimated the global burden of 
dengue to be 390 million infections per year , of 
which 96 million manifest apparently (any level 
of disease severity) ]11[. Dengue virus infection 
in humans is often unapparent, but can lead to a 
wide range of clinical manifestations, from mild 
fever to potentially fatal dengue shock syndrome 
]41[. The lifelong immunity developed after 
infection with one of the four virus types is type-
specific. 
The disease is characterized by the presence of 
fever, frontal headache, myalgia, arthralgia and 
cutaneous rash, usually self-limited to one week. 
Mild or a symptomatic infections are often  
associated with primary infections. Severe forms 
are characterized by the presence of 
hemorrhages, hypotension, thrombocytopenia 
and plasma leakage, also accompanied by 
neurological alterations ]19[, conditions that 
could eventually lead to shock and multi-organ 
failure and that could worsen in the presence of 
comorbidities. 
The majority of patients with dengue fever (DF) 
recover without complications. The mortality is 1 
– 5% without treatment and  < 1% if adequate 
treatment is provided ]19[. However, severe 
disease was reported to carry a mortality of 26% 
]34[. Predictors of mortality include shock ]29[, 
severe hepatitis (alanine transaminase (ALT)  > 
300 IU/l), altered mental status, and a history of 
bleeding at admission ]3[. Other predictors 
include a typical presentations, comorbidities, 
secondary bacterial infection and abnormal 
serum markers at presentation ]22[. 
There are no licensed vaccines or antiviral drugs 
against the disease, although some potential 
solutions are currently being studied ]16[. Early 
appropriate treatment, vector control, and 
educational program are the only current 
methods to reduce mortality and global disease 
burden ]4,41[. Therefore, the World Health 
Organization (WHO) encourages research based 
around markers of severity to develop new tools 
and methods that can reduce the healthcare 
burden of dengue infection in endemic countries. 
Dengue fever has emerged as one of the major 
public health problems in Hadhramout in recent 
years. The reported dengue outbreak in 
Hadhramout (2010) indicated the potential threat 
of dengue as public health issue ]15[ . DENV-3 
was confirmed to be the cause of an outbreak of 
dengue hemorrhagic fever (DHF) in Mukalla in 
2010 ]27[. 
In  the end of 2015, Mukalla , the capital of 
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Hadhramout governorate -Yemen, faced an 
unprecedented outbreak of dengue. During this 
largest epidemic in Mukalla city history, 
thousands became infected, hundreds were 
admitted to the hospitals, and some died ]32[. In 
this period Mukalla city and coast of 
Hadhramout under authority of Al-Qaeda 
organization and the country under political and 
military crises, for that reasons there is a lack of 
health facilities helping in diagnosis and dealing 
with dengue cases.  
In this study, we describe the clinical and 
laboratory characteristics of fatal cases of  DF 
admitted to Ibn-sina Hospital- Mukalla in the last 
large epidemic as well as the most symptoms and 
signs predicted to severe DF and death. 
 
Materials and methods: 
A prospective descriptive  study was conducted 
at Ibn-Sina Hospital- Mukalla, a tertiary care 
teaching facility. Hospital records were reviewed 
for all reported cases of dengue-related death and 
deaths among patients hospitalized with a 
diagnosis of dengue fever (DF) between the first 
week of November 2015 and last week of 
February 2016.  
In order to include deaths, dengue-related deaths 
should be reported on the  basis of clinical 
manifestation  and laboratory appearance. 
Patients who fulfilled the WHO case definition 
proposed by Tropical Disease Research (TDR) 
]41[ with supportive evidence of a dengue virus 
(DENV) infection by rapid test for dengue 
antibodies.  
Demographic details, clinical features, laboratory 
findings, and the treatment charts of death cases 
were reviewed and documented on a 
standardized form. Comorbidities were listed. 
The demographic profile of all admitted patients 
was also reviewed.  
Case definitions:  
 Case definitions based on the classification of 
Dengue fever which was proposed by Tropical 
Disease Research (TDR) and published in 
the WHO TDR 2009 dengue guidelines ]41[ 
(Table I). 
 
Table 1 : classification of Dengue fever proposed by Tropical Disease Research (TDR)]41[ 
 
 
CRITERIA Dengue type 
 
 
live in /travel to dengue endemic area . 
Fever and 2 of the following criteria: 
• Nausea, vomiting 
• Rash 
• Aches and pains 
• Tourniquet test positive 
• Leukopenia 
 
• Abdominal pain & tenderness 
• Persistent vomiting 
• Clinical fluid accumulation 
• Mucosal bleed 
• Lethargy, restlessness 
• Liver enlargement > 2 cm 
• Laboratory: increase in HCT 
              concurrent with rapid decrease 
              in platelet count  
DENGUE ± WARNING 
SIGNS 







           
         2- Dengue with warning  
             signs    
1- Severe plasma leakage 
           leading to: 
• Shock(DSS) 
 • Fluid accumulation with    
   respiratory  distress 
2- Severe bleeding 
              as evaluated by clinician 
3- Severe organ involvement 
• Liver: AST or ALT   >1000 
• CNS: Impaired consciousness 
• Heart and other organs 
3- Severe dengue fever 
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Laboratory diagnosis:  
Serum samples collected  more than  5 days after 
the onset of fever were tested for rapid anti-
dengue IgM and IgG antibodies and in early 
cases (< 3days) for rapid Nonstructural protein 1 
(NSI) antigen test. Elisa test for dengue 
antibodies was used only to prove  dengue 
epidemic by health authorities (due to limited 
resources). RT-PCR was not performed on our 
cases due to unavailability. 
 
Data analysis:  
Data were analyzed using SPSS statistical 
software version 21. Frequencies of different 
categorical variables were calculated. The 
median and range were calculated for continuous 
variables (due to presence of unusual extremity, 
mean is not taken) . Patient characteristics were 
compared using the Chi-square test or Fisher’s 
exact test for categorical variables. The Mann  – 
Whitney test was used for continuous variables. 
A 1-sided  p < 0.05 was considered to be 




A total of 424 patients with dengue fever were 
hospitalized; 272 (64.15%) were males, 152 
(35.85%) were females. Of them, eighteen death 
cases were reported, resulting in a mortality rate 
of approximately 4.25% of all cases. All of these  
death cases were older  than 15 years. The 
median age was 26 years (range 17 – 50 y) . 
There  were 10  (55.6%)  males and  8  (44.4%) 
females with M:F raio (1.25:1). Females were 
approximately equal to males (median age of 
females was 25 years, range 17 – 50 years versus  
median age of males was 26 years, range 19 – 46 
years). Most of dead  cases were from Fuwwah 






Fig.1: Geographical distribution of fatal dengue case 
 
Clinical features:  
The majority of patients (70%) had become 
afebrile at the time of admission. The most 
common presenting complaints were arthralgia 
and myalgia (94.4%) and headache (88.9%), 
while the common warning symptoms  were 
persisting vomiting (66.7%), abdominal pain and 
tenderness (61.1%), bleeding (44.4%) and altered 
mental status and convulsion (38.9%). The 
common presenting signs were shock ( Blood 
Pressure (BP) ≤ 90mm/Hg) and tachycardia ( ≥ 
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Table 2: Clinical presentations of fatal dengue cases according to gender 
 
The most common diagnosis at the time of 
presentation was severe dengue (SD). There was 
no statistically significant difference between 
male and female patients in terms of duration of 
illness and duration of hospital stay. 
  
Laboratory findings : 
Laboratory findings of these patients are depicted 
in Table 3. Leukocytosis (total leukocyte count 
>10,000/mm
3
 ) was seen in 5 (28%) patients at 
admission. The cause of leukocytosis was found 
to be bacterial encephalitis in 3 patients, reactive 
due to bleeding in two cases. At presentation, 
both females and males had significantly normal 
to lower hematocrit (Htc) (median range: 35 (31  
– 44) vs 41 (23 – 45)). The increase in the 
aspartate transaminase (AST) level was higher 
than that of alanine transaminase (ALT) (median 
range: 80IU/L (40  – 5300 IU/L) vs 60 IU/L (40 
– 4440 IU/L)). 
IgM & IgG rapid anti-dengue antibodies was 
positive in 9 patients and non- structural protein 
1 (NS1) was positive in 9 patients. 
 
Table 3: Para clinical finding in fatal dengue cases among males and femles. 
 
Total and % F M Investigation 
16 (88.8) 8 (44.4) 8 (44.4) Platelet <100000 
10 (55.5) 4 (22.2) 6 (33.3) Total leukocyte count < 4000 
5 (27.7) 3 (16.6) 2 (11.1) Total leukocyte count > 10000 
14(77.7) 6 (33.3) 8 (44.4) Albumin < 3.5 
0(0) 0 0 Htc > 20% elevation 
4(22.2) 2 (11.1) 2 (11.1) PTT >35 
2(11. 2) 1 (5.6) 1 (5.6) PT >15 
3(16.7) 1 (5.6) 2 (11.1) AST > 25 
1(5.6) 0 1(5.6) ALT> 25 
2(11. 2) 1(5.6) 1(5.6) Bilirubin >1.5 
 
Cause of death: 
The cause of death was multifactorial in most of 
cases, arranged from dengue shock, fulminant 
hepatitis with hepatic encephalopathy, 
encephalitis, intracerebral hemorrhage, acute 
respiratory distress syndrome (ARDS), renal 
failure and pulmonary edema due to over 
hydration. In females, the most causes of death 
were Dengue shock alone (5cases, 62.5% of total 
female deaths ) or with encephalitis (2cases, 25% 
of total female deaths)) and hepatic 
encephalopathy(I case, 12.5% of total female 
Clinical features M & % F & % Total number of cases 
(%) 
Arthralgia and Myalgia 10 (55.5) 7 ( 38.9) 17(94.4) 
Headache 9 (50) 7 (38.9) 16(88.9) 
Persisting Vomiting 6 (33.3) 6 (33.3) 12(66.6) 
Ret orbital pain 8 (44.4) 3 (16.7) 11(61.1) 
Abdominal pain and 
tenderness 
7 (38.9) 4 (22.2) 11(61.1) 
Bleeding 4 (22.2) 4 (22.2) 8(44.4) 
Hypotension and Shock ≤90 3 (16.6) 5 (27.8) 8(44.4) 
Tachycardia ≥100 5 (27.8) 3 (16.6) 8(44.4) 
Convulsions 5 (27.8) 2 (11.1) 7(38.9) 
Loss of consciousness 5 (27.8) 2 (11.1) 7(38.9) 
Ascites and pleural effusion 3 (16.6) 0 3(16.6) 
Pulse pressure ≤ 20 1 (5.6) 2 (11.1) 3(16.7) 
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deaths). Three patients also had previous illness 
of Diabetes, chronic liver disease and Bronchial 
asthma and participating death due to diabetic 
ketoacidosis with renal failure, hepatic 




Fig.2: causes of fatal dengue cases 
 
DSS: dengue shock syndrome, ARDS: acute respiratory distress syndrome, 
H.: hepatic, P. :pulmonary, RF: renal failure, ICH: intracranial hemorrhage. 
 
A comparison of early (within 24 hours of 
presentation) versus late (more than 24 hours 
after presentation) deaths revealed that cases of 
early death were significantly equal in age ,sex, 
and comorbidities, and other finding. (Table 4).
 
Table 4: Comparison of the clinical and laboratory profiles of early versus late deaths 
 
p- value Late deaths Early deaths Character 
0.64 9(50%) 9 (50%) n & % 
0.32 30(19-40) 27.2(17-50) Age, y 
0.64 2:1 0.8:1 Sex 
1.0 5(55.6%) 6(66.7%) Abdominal pain and tenderness 
0.62 7(77.8%) 5(55.6%) Persisting Vomiting 
1.0 4(44.4%) 3(33.3%) Alter consciousness 
0.86 4(44.4%) 4(44.4%) Bleeding 
1.0 2(22.2%) 1(11.1%) Plasma leakage 
0.21 110(70-140) 80(0-130) Systolic Bp mmHg 
0.39 70(50-90) 50(0-80) Diastolic BpmmHg 
0.44 40(20-50) 40(0-60) Pulse pressure mmHg 
0.38 0(0-2) 0(0-1) Comorbidities 
0.58 40(28-43) 37(0-45) Htc at presentation(%) 
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A three (15.9%) patients had at least 1 
comorbidity. The number of comorbidities was 1 
in 2 patients (5.3%) , and 2 in one patient 
(10.6%) (Figure 3). The duration of hospital stay 
was variable: mean = 70 hours , range = 1-312 
hours. 
Two (11.12%) patients received more than 4 
platelet  transfusions, one (5.6%) patient received 
a blood transfusion. Transfusions did not 
produce sustained improvements in the 
coagulation status and has no direct relation to 
deaths in the study. 
 
Discussion: 
This series of cases serves to characterize the 
mortality associated with adult dengue virus 
infection during an epidemic outbreak in 
Mukalla city, capital of hadhramout – yemen.. 
Our study showed that most of fatal cases were 
male. This correlates with the male to female 
ratio of hospitalized patients. In terms of 
prevalence of the disease, a male preponderance 
has been observed in Saudi Arabia ]9,37[ and 
other Asian countries ]6[, but not in China, 
Malaysia, America or Bangladesh ]17,36,43[. 
The exact cause of this difference is unknown, 
but it could be related to higher exposure to the 
vector in males during daylight and less in 
females due to  social  reasons  and  to  their  
wearing  of  Hijab. Studies have conflicting 
evidence on the association of gender with 
severe dengue or dengue-related death. A meta-
analysis, and studies in Singapore, Vietnam and 
Malaysia found that female gender was 
associated with severe dengue]5,19,36,42[. 
However, a study in France showed that male 
gender was associated with severe dengue 
manifestations ]39[. It is unclear by which 
mechanism the age and gender affects the 
disease manifestation and outcomes ]24[. 
Most of fatal cases were from Mukalla and 
Fuwwah neighborhoods (n=9, 47.37%) and those 
areas had significant number of cases due to poor 
sanitary status , presence of stagnated water 
pools and houses yards. 
 Most of death cases in this study were afebrile 
,which means that the most critical period of the 
disease is the defervescence of fever, may arise 
when the signs of circulatory failure and 
hemorrhagic manifestations, which occurs 
around the third and fourth days of the disease. 
This finding was similar to other studies ]29, 33[. 
This study found that persistent vomiting, 
abdominal pain and tenderness, bleeding, 
hypotension and tachycardia, convulsion, 
disturbance level of consciousness and severe 
plasma leakage were associated with dengue 
related mortality in the overall population like 
other worldwide studies ]3,8,18,22,24,25,33,35[. 
Nausea and/or vomiting should be considered as 
an early warning sign that can alert the attending 
health care practitioner to monitor such patients 
closely ]25[. Nausea and vomiting were also 
found to be associated with dengue shock 




. Bleeding, shock and severe plasma 
leakage are late manifestations in our study 
similar to other studies in Pakistan and Singapore 
]3,24[. 
Most patients presented with gum bleeding, 
epistaxis, hemoptysis , hematemesis and vaginal 
bleeding or mixed sites of bleeding and mostly 
had mild bleeding episodes did not require any 
transfusion, except in rare cases in contrast of 
other study who required transfusions ]2[.   
Most death cases in our study and other studies 
had low platelet count less than 
100,000/cells/mm
3
 ]3,13,25,30[ and low albumin 
with ascites ]2,19,36[. Although hematocrit is 
regarded as a marker for plasma leakage in WHO 
guidelines, it was not elevated in any death cases 
in our study. Therefore, like some other studies, 
hematocrit may not be considered as a sensitive 
marker of plasma leakage and has low predictive 
value in our study ]28,35,36[.This may be 
because most patients presented with bleeding, 
and their baseline hematocrit before admission 
was not known, and even urgent volume 
replacement can modify this parameter. The 
important warning laboratory investigations 
associated with severe dengue and death in this 
study were elevated liver enzymes, and 
prolongation of activated partial thromboplastin 
time with rapid reduction in platelet count like 
other studies]2,13,42[. 
Dengue infection usually causes leukopenia ]1[ , 
Leukocytosis was observed in a significant 
proportion of our patients (27.8%). Leukocytosis 
may result from secondary infection or reactive 
due to bleeding. Secondary bacterial infection on 
presentation has been postulated to  be a 
predictor of death from dengue ]7,22[. 
Severe dengue fever was the most common 
diagnosis of fatal dengue cases in our study, with 
shock, hepatic encephalopathy, encephalitis and 
acute respiratory distress syndrome were the 
most common causes of deaths like most of the 
studies ]3,10,19,22, 29[
 
somewhat differ from 
another study where severe bleeding, multi-organ 
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failure and coagulopathy were the primary 
causes of deaths ]36[. 
Shock has been reported as an important factor 
for mortality with or without a history of 
associated blood loss ]3,29[. It present in 8 
(44.4%) cases, without the association of major 
bleeding, and was the most important cause of 
death. Shock  itself is an alarming presentation in 
patients with  dengue virus infection and as an 
indicator  of the severity of disease ]7,24[. The 
association between being female gender and 
risk of shock is not fully understood (since most 
shocked death cases are females (5 out of 8 
cases), but may be explained by gender 
differences in seeking healthcare as well as 
physical characteristics]5,19[.  
Liver damage and neurological complications 
(encephalitis) were found to be strongly 
associated with shock in our study, probably due 
to the sequelae of shock, systemic inflammation, 
and direct viral invasion into the organs similar 
to other studies ]8,19,31[. Fulminant hepatic 
failure has been reported as the most common 
cause of encephalopathy in DF ]29,31[. The 
elevation of transaminases was mild to moderate 
in most cases, but was 10-fold greater than the 
normal upper limit for AST and ALT in 16.7% 
and 5.4% of our patients as mentioned in other 
literature ]20[ indicating that it is an important 
warning signs of dengue fever. In contrast to 
other viral infections which involve the liver, the 
AST (SGOT) levels were much higher than ALT 
(SGOT) levels in our study and also other studies 
]3,20[. The most frequent neurological 
manifestations were reduced consciousness and 
convulsions, and encephalitis is one of common 
cause of this complication in our study like other 
studies ]31,38[. 
Acute renal failure has a worse prognosis in 
patients with dengue infection ]21,35,36[, and it 
was resulted from shock state or bleeding 
associated with DF]10[ as occurred in two of our 
patients . A small proportion of patients 
(n=3,15.6%) had co-morbidities like diabetes, 
asthma and chronic liver disease which was less 
than other studies ]10,18,23[, but studies showed 
that comorbidities were important predictors of 
mortality in DF ]10,18,22,24,36[.  
Patients who died within 24 hours of 
presentation and after that, had no significant 
differences. This implies that more hospital stay 
has not  impact on dengue related deaths in 
contrast to other studies ]7,24[. In contrast to 
other studies ]7,26[ that reported increase 
mortality in dengue patients after transfusion of 
blood products, our study showed no such 
linkage and there is no evidence of death after 
platelet transfusions. 
A limitation of this study is the fact that RT-PCR 
or IgM ELISA was not used to confirm the 
diagnosis due to unavailability. Rapid IgM and 
IgG and NSI tests were used in nearly all cases, 
and it has high specificity and sensitivity]14,40[. 
However, a diagnosis of severe dengue was 
established when criteria were fulfilled, even in 
the absence of specific diagnostic testing. 
 
Conclusion: 
The mortality rate of dengue cases was 
approximately 4.25% of all probable cases. 
Death cases were more among male patients, and 
from Fuwwah and Mukalla city. Alarming signs 
of dengue-related deaths include  nausea, 
vomiting, abdominal pain and tenderness as early 
symptoms, and plasma leakage, altered mental 
status and convulsion as a late signs. Monitoring 
of the clinical and laboratory parameters  
includes leukocytosis, elevated liver enzymes 
and rapid decline in platelets.  Cautious use of 
antipyretics, fluids, and blood products to 
provide adequate intravascular volume while 
avoiding fluid overload are important and can 
reduce mortality. 
Dengue  shock were responsible for most of the 
dengue-related deaths, followed by hepatic 
encephalopathy and encephalitis. Comorbidities 
and secondary infections were an important 
factors that can increase the mortality. 
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 سباب وعالمات اخلطورةألحضرموت: ا -الت الضنك يف املكالوفيات حا
 
  أحمد مبارك دعكيك                      عبدالرحيم عبداهلل باحشوان                 




 2016لى فبراير  إ 2015فترة وباء الحمى من نوفمبر عممت هذه الدراسة الوصفية لمراجعة حاالت الوفاة المرتبطة بحمى الضنك خالل 
المعمومات السريرية والمخبرية اليمن . تمت مراجعة وفيات حمى الضنك خالل فترة الوباء وتم استخالص  –حضرموت  -في المكال
حمى  قسمين حمى الضنك قّسمتوالتي  2002بحوث األمراض المستوطنة لعام  -وتصنيف الحاالت حسب دليل منظمة الصحة العالمية 
 حالة تم ترقيدها بقسم الباطنة بمستشفى ابن سيناء ألصابتها بحمى424ضنك مع أعراض الخطورة وحمى الضنك الشديدة. من مجموع ال
سنة. 26%( نساء. متوسط العمر44) 8%( حاالت رجال و 5556)10%( متعمقة بحمى الضنك,4.25حالة وفاة ) 18الضنك تم رصد 
مراض أخرى مزمنة. أ%( حاالت كانت تصاحبها 1556)3.  كل الحاالت المتوفاة تم تشخيصها بحمى الضنك الشديدة عند وصولها
الوفاة. وكان الغثيان, هم اسباب أة الضائقة التنفسية الحادة كانت التهاب الدماغ و متالزمالصدمة الضنكية , التهاب الكبد الشديد, ك
م البطن ,انخفاض الضغط, اختالل الوعي, التشنجات, ارتفاع كريات الدم البيضاء واالنخفاض السريع لمصفائح الدموية من أهم آالالقيء, 
 .مؤشرات الخطورة لحمى الضنك الشديدة ووفياتها
 .ضنك, حمى الضنك الشديدة, المكال, اليمنل: حمى امات المفتاحيةالكم
 
 
 
 
 
